Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Molnupiravir  COVID-19 treatment studies for Molnupiravir  C19 studies: Molnupiravir  Molnupiravir   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   All Outcomes   Recent:  

Molnupiravir: coding for catastrophe

Malone et al., Nature Structural & Molecular Biology, doi:10.1038/s41594-021-00657-8 (Review)
Malone et al., Molnupiravir: coding for catastrophe, Nature Structural & Molecular Biology, doi:10.1038/s41594-021-00657-8 (Review)
Sep 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Review of recent studies on molnupiravir's mechanism of lethal mutagenesis. Authors note that potential off-target effects require further investigation, because molnupiravir may be mutagenic to host DNA during host DNA replication.
Malone et al., 13 Sep 2021, peer-reviewed, 2 authors.
All Studies   All Outcomes   Submit Updates or Corrections
This PaperMolnupiravirAll
news & views
Antiviral Therapeutics, Brandon Malone, Elizabeth A Campbell
Molnupiravir: coding for catastrophe Molnupiravir, a wide-spectrum antiviral that is currently in phase 2/3 clinical trials for the treatment of COVID-19, is proposed to inhibit viral replication by a mechanism known as 'lethal mutagenesis'. Two recently published studies reveal the biochemical and structural bases of how molnupiravir disrupts the fidelity of SARS-CoV-2 genome replication and prevents viral propagation by fostering error accumulation in a process referred to as 'error catastrophe'.
Competing interests The authors declare no competing interests. Is it a wrap? Nucleosome interactions of the BRCA1-binding partner, BARD1, steal the scene emerging findings provide compelling evidence that the bRCA1-binding partner bARD1 contributes yet further to bRCA1 function. bARD1 is crucial for positioning the e2 ubiquitin-conjugating enzyme that confers specificity of its ligase to residues on histone H2A, and bARD1 also promotes DNA damage-induced chromatin recruitment through an interaction with ubiquitin-conjugated Lys13 or Lys15 of H2A on the nucleosome core particle. Nature Joanna R. Morris T he BRCA1-BARD1 complex is a crucial tumor suppressor that is linked to the prevention of familial breast and ovarian cancers. The heterodimer has several proposed functions, including the regulation of DNA resection and the promotion of RAD51 loading through PALB2-BRCA2, which is required for homology-directed DNA repair. Despite the tremendous focus in the decades since the discovery of the BRCA1 gene, several critical questions have remained, if not completely unanswered, then with unsatisfactory solutions. Although a complete literature review is not possible here, some pertinent observations are that recruitment of BRCA1-BARD1 to damaged chromatin occurs through the
References
Agostini, None, J. Virol
Bouvet, Proc. Natl Acad. Sci
Gordon, None, J. Biol. Chem
Gordon, Tchesnokov, Schinazi, Götte, None, J. Biol. Chem
Hall, None, J. Infect. Dis, doi:10.1093/infdis/jiab305
Jena, None, Phys. Chem. Chem. Phys. PCCP
Kabinger, None, Nat. Struct. Mol. Biol, doi:10.1038/s41594-021-00651-0
Sheahan, None, Sci. Transl. Med
Smith, Blanc, Vignuzzi, Denison, None, PLOS Pathog
Sticher, None, Antimicrob. Agents Chemother
Toots, None, Sci. Transl. Med
Urakova, None, J. Virol
Vicenti, Zazzi, Saladini, None, Expert Opin. Ther. Pat
Wahl, None, Nature
Yoon, None, Antimicrob. Agents Chemother
Zhou, None, J. Infect. Dis, doi:10.1093/infdis/jiab2
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit